In this work, compared with non-Cu 2 In nanoalloy counterpart Cu-In/ZrO 2 catalysts, a Cu 1 In 2 Zr 4 -O catalyst with the structure of Cu 2 In alloy exhibited an excellent performance for CO 2 hydrogenation to CH 3 OH. CO 2 conversion (12.8%) and methanol selectivity (72.8%) were outstandingly higher, which indicated that the synergetic effect existed between Cu and In over the Cu 1 In 2 Zr 4 -O catalyst. The formation of Cu 2 In alloy caused high dispersion of the active species and high surface area of the Cu 1 In 2 Zr 4 -O catalyst, enhancing catalyst reduction performance. Strong adsorption of CO 2 caused a good conversion property of the Cu 1 In 2 Zr 4 -O catalyst. The strong interaction between the In and Cu species formed a nanoalloy and decreased the catalyst reduction temperature, which led to the high catalytic performance for CO 2 hydrogenation. The Cu 2 In alloy rather than metallic Cu was the key active site for the methanol formation.
No takes yet. Share an insight, caveat, or question.
Gao et al. (2020) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: